|
|||||
|
|
Validation of distinct type 2 diabetes clusters and their association with diabetes complications in the DEVOTE,LEADER and SUSTAIN-6 cardiovascular outcomes trials |
|
| Authors: | Anna R. Kahkoska PhD Milan S. Geybels PhD Klara R. Klein MD Frederik F. Kreiner PhD Nikolaus Marx MD Michael A. Nauck MD Richard E. Pratley MD Benjamin O. Wolthers MD John B. Buse MD |
| Affiliation: | 1. School of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA;2. Novo Nordisk A/S, Søborg, Denmark;3. Department of Internal Medicine I, University Hospital Aachen, RWTH Aachen University, Aachen, Germany;4. Medical Department I, Diabetes Center Bochum-Hattingen, St. Josef-Hospital, Ruhr-University Bochum, Bochum, Germany;5. AdventHealth Translational Research Institute, Orlando, Florida, USA |
| Abstract: | |
| Keywords: | cardiovascular disease diabetes complications GLP-1 hypoglycaemia insulin analogues type 2 diabetes |